Volume 5, Issue 3: Spring 2017: Advances in HBV Therapies

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 3)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Identify patients with chronic hepatitis B for antiviral therapy and evaluate patients with indeterminate HBV phenotypes.
  • Describe the efficacy, safety, and limitations of current FDA-approved nucleos(t)ide analogues.
  • Discuss how the mechanisms of actions of emerging therapeutic agents affect the HBV life cycle.
 

 

Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
04/27/2017
Course expires: 
04/28/2019
Cost:
$0.00
Daryl T. Y. Lau, MD, MSc, MPH
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
 
 

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
04/27/2017
Course expires: 
04/28/2019

Price

Cost:
$0.00
Please login or register to take this course.